Nearing Completion, Revolution Labs Cements Lexington’s Life Sciences Growth
Revolution Labs, a 180,000 square foot office and lab space in Lexington, Massachusetts, is on track for completion. Callahan Construction recently held a “topping off” ceremony for the new space lab, which speaks to the life sciences development trend taking hold in the region.
Revolution Labs is located at 1050 Waltham Street, positioned at the center of Greater Boston’s life science cluster along Routes 128 and 2. The development will offer occupants a superior work environment and a 442-space standalone precast garage with a solar canopy, along with electric vehicle charging stations and shuttle service to Alewife MBTA station. In addition, it will feature a cutting-edge lab infrastructure and is aiming for LEED Gold and WELL Building certifications for environmental sustainability and occupant health and wellbeing.
The new building is expected to be ready for occupation in the fourth quarter of 2022 and will feature purpose-built laboratory infrastructure, full-service onsite amenities and multi-functional outdoor spaces. It will accommodate leading life science firms, many of which have been turning toward Lexington and surrounding towns to capitalize on the growing biotechnology industry located here.
The property was developed by Greatland Realty Partners, a Boston-based real estate management and development firm. Callahan Construction is the general contractor for the project.
Kevin Sheehan, co-founder and managing partner at Greatland Realty Partners, is excited to bring another project to Lexington's booming life science construction portfolio. “With the Revolution Labs project, it was our goal to continue to add value in the Greater Boston life science market with a design focused on the end user. I am proud to say in collaboration with our valued partners, we are well on our way to achieving that goal,” Sheehan said in a statement.
Callahan President Patrick Callahan also expressed excitement with the project. “Over the course of the past few years we have seen substantial growth in our execution of life science and R&D construction projects," he said. “We are excited to bring another project to the booming Route 128 Central Corridor.”
Lexington has become a hub for pharmaceutical, medical and biotechnology companies since the local government signed a $1 billion life sciences bill to build up the industry in the state in 2008. Massachusetts Gov. Charlie Baker reauthorized this in 2019, signing a $623 million bill.
MassBio, a not-for-profit organization representing life science entities and member communities and organizations, reported that more than 16.5 million square feet of commercial lab space have been built over the last ten years, all of which is full.